Argyle Capital Management, LLC / BMY
Argyle Capital Management, LLC’s Bristol-Myers Squibb Co Position
Does Argyle Capital Management, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 71.2K shares worth $4M (+1.40% of its 13F portfolio) as of Q1 2026, down from 72.0K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
71.2K
% of Portfolio
+1.40%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 71.2K | $4M | +1.40% |
| Q4 2025 | 72.0K | $4M | +1.30% |
| Q3 2025 | 68.7K | $3M | +1.07% |
| Q2 2025 | 68.9K | $3M | +1.16% |
| Q1 2025 | 68.7K | $4M | +1.56% |
| Q4 2024 | 67.4K | $4M | +1.50% |
| Q3 2024 | 64.8K | $3M | +1.34% |
| Q2 2024 | 64.1K | $3M | +1.09% |
| Q1 2024 | 65.5K | $4M | +1.37% |
| Q4 2023 | 64.6K | $3M | +1.37% |
| Q3 2023 | 72.8K | $4M | +1.55% |
| Q2 2023 | 68.2K | $4M | +1.57% |
| Q1 2023 | 73.7K | $5M | +1.80% |
| Q4 2022 | 74.1K | $5M | +1.83% |
| Q3 2022 | 74.1K | $5M | +2.05% |
| Q2 2022 | 74.1K | $6M | +2.05% |
| Q1 2022 | 74.7K | $5M | +1.78% |
| Q4 2021 | 78.9K | $5M | +1.54% |
| Q3 2021 | 78.9K | $5M | +1.55% |
| Q2 2021 | 78.9K | $5M | +1.70% |
| Q1 2021 | 78.9K | $5M | +1.68% |
| Q4 2020 | 78.9K | $5M | +1.82% |
| Q3 2020 | 79.1K | $5M | +1.95% |
| Q2 2020 | 79.9K | $5M | +1.97% |
| Q1 2020 | 80.2K | $4M | +2.11% |
| Q4 2019 | 80.3K | $5M | +1.83% |
| Q3 2019 | 81.2K | $4M | +1.56% |
| Q2 2019 | 80.6K | $4M | +1.39% |
| Q1 2019 | 80.4K | $4M | +1.47% |
| Q4 2018 | 80.4K | $4M | +1.77% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of BMY.